Showing results (341-350 of 359) with videos related to
Sort By:
Pageof 36
Nature Aging|January 29, 2025
Niche-derived Semaphorin 4A safeguards functional identity of myeloid-biased hematopoietic stem cellsDorsa Toghani, Sanika Gupte, Sharon Zeng, et al.Cell Reports|February 10, 2015
Niche-Based Screening in Multiple Myeloma Identifies a Kinesin-5 Inhibitor with Improved Selectivity over Hematopoietic ProgenitorsShrikanta Chattopadhyay, Alison L Stewart, Siddhartha Mukherjee, et al.Blood|November 23, 2020
Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALLPraveen Anand, Amy Guillaumet-Adkins, Valeriya Dimitrova, et al.Blood Advances|December 5, 2023
Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemiaAndrew A Lane, Jacqueline S Garcia, Evangeline G Raulston, et al.Nature Chemical Biology|October 29, 2013
Niche-based screening identifies small-molecule inhibitors of leukemia stem cellsKimberly A Hartwell, Peter G Miller, Siddhartha Mukherjee, et al.Nature Cardiovascular Research|June 24, 2022
Bone marrow endothelial dysfunction promotes myeloid cell expansion in cardiovascular diseaseDavid Rohde, Katrien Vandoorne, I-Hsiu Lee, et al.Nature Medicine|December 9, 2014
Mutations in G protein β subunits promote transformation and kinase inhibitor resistanceAkinori Yoda, Guillaume Adelmant, Jerome Tamburini, et al.Nature Communications|April 28, 2022
Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cellsTianyu Cai, Agnès Gouble, Kathryn L Black, et al.The Journal of Experimental Medicine|January 25, 2012
Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibitionOliver Weigert, Andrew A Lane, Liat Bird, et al.Blood Neoplasia|March 12, 2026
Synergistic targeting of eIF4A-mediated translation initiation and apoptosis in acute myeloid leukemiaYoke Seng Lee, Jonathan D Good, Noha Awais, et al.Pageof 36